Asia-Pacific Insurance Market Faces Double-Digit Medical Inflation for Third Consecutive Year

SINGAPORE – For the third consecutive year, medical costs across Asia-Pacific are projected to increase by double digits, with insurance providers forecasting a 12.3 percent rise in 2025 compared to 11.9 percent in 2024, presenting sustained challenges for individuals and employers struggling to manage healthcare expenditures, according to comprehensive research conducted by WTW.

The Global Medical Trends Survey, which gathered input from 348 leading health insurers representing 75 countries during mid-2024, reveals that Asia-Pacific is projected to experience the highest medical inflation globally. Survey respondents identified increased utilization of health services, rising pharmacy costs and proliferation of new medical technologies as primary drivers of escalating overall medical expenses.

More than three-quarters of insurers in Asia-Pacific – 76 percent – anticipate higher or significantly higher medical trends over the next three years, representing the highest proportion among all global regions surveyed. This pessimistic outlook reflects structural challenges within healthcare systems that show little sign of abating despite various policy interventions.

Medical cost growth varies significantly across markets within the region. Indonesia leads with a projected 19.4 percent increase, followed by Philippines at 18.3 percent and Malaysia at 16.4 percent. New Zealand expects 16 percent growth while Thailand forecasts 14.2 percent escalation. India anticipates 13.2 percent increases with Singapore projecting stable but elevated growth of 12 percent. South Korea, Vietnam, Australia, Taiwan, China and Hong Kong round out regional projections with increases ranging from 9.8 to 11.9 percent.

Singapore's medical insurance cost increase is expected to stabilize at 12 percent in 2025, similar to 2024 levels, though the trend remains elevated over longer time horizons. The government continues investing in population health improvements, making workforce wellbeing and preventive care increasingly important priorities for companies seeking to build future-ready organizations capable of meeting challenges ahead.

Audrey Tan, Head of Health & Benefits for Southeast Asia and Singapore at WTW, emphasized that Singapore's medical inflation rate appears to be entering a stable trend in 2025 despite remaining significantly above general economic inflation. She noted the importance of companies focusing on workforce wellbeing with high emphasis on preventive care to address varying demographics in contemporary workplaces.

The Asia-Pacific insurance market was valued at $2.28 trillion in 2024 and is estimated to reach $2.63 trillion in 2025, with projections indicating growth to $8.38 trillion by 2033 at a compound annual growth rate of 15.56 percent. This expansion reflects not only medical cost inflation but also broadening insurance penetration across emerging markets as middle-class populations grow and demand comprehensive coverage.

Survey participants identified increased utilization or misuse of care due to lack of integration between primary, specialty and facility care as a top concern, cited by 51 percent of respondents. External factors including higher costs resulting from new medical technologies were mentioned by 73 percent, making it the leading driver. Decline in quality or funding of public health systems was cited by 40 percent while plan designs with little or no cost-sharing – highest among all regions at 39 percent – also contributed to inflation pressures.

Notably, mental health does not appear on the Asia-Pacific list of top conditions by incidence in the last 18 months, making it the only region globally where this factor is absent. However, incidences of breast, colorectal and lung cancer are growing faster in Asia-Pacific compared to global averages, highlighting disease burden shifts requiring specialized medical interventions.

The health protection gap across 12 surveyed Asian markets reached $258 billion in premium equivalent terms during 2024, based on the share of healthcare costs that households find financially stressful. This represents a 21 percent increase compared to 2017 when previous consumer surveys on stressful out-of-pocket healthcare expenditure were conducted.

Most of the gap stems from emerging Asia, with China accounting for over half the region's total due to its massive population and growing household healthcare spending on modern treatments. However, these estimates do not capture the non-treatment gap resulting from affordability and availability issues, likely understating vulnerability levels in countries like India where many households cannot access healthcare at all.

The mortality protection gap for the same Asian markets reached $132 billion in premium equivalent terms during 2024, reflecting a 35 percent increase from 2017. This gap represents rising income replacement needs of an expanding middle class combined with relatively low life insurance uptake, especially in emerging markets where household incomes and protection needs have surged while insurance adoption has not kept pace.

Government schemes designed to increase public healthcare coverage have expanded in several countries including large-scale public insurance initiatives in Indonesia, India and Thailand. Nevertheless, gaps remain in coverage adequacy and accessibility, with chronic conditions and critical illnesses representing leading sources of stress-related spending for many households.

Cigna Healthcare's recent appointment of Rob Peat as regional president for Asia-Pacific operations underscores industry recognition of the market's strategic importance. Peat, who has spent more than two decades with the organization, will oversee operations across Hong Kong, Singapore, mainland China and Australia while supporting business growth and exploring synergies among different markets.

Physical health emerged as the top priority for 39 percent of respondents in Cigna's regional survey covering eight markets, ahead of financial wellbeing at 32 percent and mental wellbeing at 29 percent. Healthcare cost inflation was identified as a dominant concern for 75 percent of participants, with average perceived inflation rates reaching 23 percent – more than twice actual inflation levels.

Despite concerns, critical illness insurance remains significantly underutilized with only 18 percent of respondents reporting coverage compared to 32 percent holding accident insurance, 32 percent with inpatient coverage and 26 percent possessing outpatient insurance. This protection gap leaves many families vulnerable to catastrophic financial shocks should serious illness occur.

Singapore's general insurance market demonstrates positive momentum, with gross written premiums projected to increase 6.7 percent in 2025 according to GlobalData analysis. Personal accident and health insurance is expected to remain the largest segment, representing more than a third of total market premiums while experiencing substantial growth driven by medical inflation, demographic changes and product innovation.

Industry observers recommend that insurers and employers adopt several strategies to manage rising costs effectively. These include promoting preventive care through screenings, early detection measures and educational campaigns; ensuring benefits remain fit for purpose by reviewing programs to match population needs; implementing value-based care models; leveraging technology and data analytics; and exploring alternative payment arrangements with providers.

Looking ahead, sustained medical inflation presents ongoing challenges for individuals, employers and governments across Asia-Pacific. Without structural reforms addressing root causes of cost escalation – including inefficient care delivery models, misaligned incentives and inadequate emphasis on prevention – the region will continue experiencing double-digit healthcare expense growth that strains household budgets and limits access to essential services for vulnerable populations.